Freshly Manufactured 35kDa Hyaluronan Fragment HA35 for the Treatment of Chronic Wounds

• Status: Completed
• Trial end date: 2023-02-08
• Target enrollment: 0
• Participant gender: All

Summary

In this research, the patients with chronic wounds accompanied by pain were treated by injecting freshly manufactured tissue permeable hyaluronan fragment HA35 into the tissue under the heath skin immediately surrounding the chronic wounds.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nakhia Impex LLC
• Collaborator: Mongolian National University of Medical Sciences
• Treatments: Pharmaceutical Solutions

Criteria

Inclusion Criteria:

1. The chronic wounds of painful diabetic wounds, venous wounds, arterial wounds, traumatic and pressure wounds which had not been closed more than 3 months.

2. All the chronic wounds were clinically presented by surface darkeness and purulent secretions on the wounds, and darkness or redness, swelling, dryness and broken.

3. Surface of the skin immediately surrounding the wounds.

4. Subject agrees to be compliant with study related visit and treatment schedule.

5. Written informed consent.

Exclusion Criteria:

1. History of wound healing abnormalities or a medical condition that is known to be associated with abnormal wound healing.

2. Subjects with any known coagulation disorder.